- Aberrant Regulation of mRNA m6A Modification in Cancer Development
Junyun Luo et al, 2018, IJMS CrossRef - Functions of RNA N6-methyladenosine modification in cancer progression
Bing Chen et al, 2019, Mol Biol Rep CrossRef - Current Clinical Strategies of Pancreatic Cancer Treatment and Open Molecular Questions.
Maximilian Brunner et al, 2019, Int J Mol Sci CrossRef - microRNAs Tune Oxidative Stress in Cancer Therapeutic Tolerance and Resistance
Wen Cai Zhang, 2019, IJMS CrossRef - Multiple Functions and Mechanisms Underlying the Role of METTL3 in Human Cancers
Wenhui Zheng et al, 2019, Front. Oncol. CrossRef - N6-Methyladenosine: A Novel RNA Imprint in Human Cancer
Sihui Yu et al, 2019, Front. Oncol. CrossRef - VIRMA-Dependent N6-Methyladenosine Modifications Regulate the Expression of Long Non-Coding RNAs CCAT1 and CCAT2 in Prostate Cancer
Daniela Barros-Silva et al, 2020, Cancers CrossRef - Analysis of Genetic Alteration Signatures and Prognostic Values of m6A Regulatory Genes in Head and Neck Squamous Cell Carcinoma
Xuanchen Zhou et al, 2020, Front. Oncol. CrossRef - Molecular mechanism of methyltransferase-like protein family: Relationship with gastric cancer
Jing Wang et al, 2020, WCJD CrossRef - Immuno-Surgical Management of Pancreatic Cancer with Analysis of Cancer Exosomes
Yu Takeda et al, 2020, Cells CrossRef - Prognostic Value of an m6A RNA Methylation Regulator-Based Signature in Patients with Hepatocellular Carcinoma
Xiaomin Wu et al, 2020, BioMed Research International CrossRef - Identification of pathology-specific regulators of m6A RNA modification to optimize lung cancer management in the context of predictive, preventive, and personalized medicine
Na Li et al, 2020, EPMA Journal CrossRef - m6A RNA Methylation Regulators Participate in the Malignant Progression and Have Clinical Prognostic Value in Lung Adenocarcinoma
Fangwei Li et al, 2020, Front. Genet. CrossRef - Expression Pattern and Prognostic Value of Key Regulators for m6A RNA Modification in Hepatocellular Carcinoma
Lele Zhang et al, 2020, Front. Med. CrossRef - null
María José López-Ibarra et al, 2020 CrossRef - IGF2BP2 Promotes Liver Cancer Growth Through an m6A-FEN1-Dependent Mechanism.
Jian Pu et al, 2020, Front Oncol CrossRef - Characterization of Oral Microbiome and Exploration of Potential Biomarkers in Patients with Pancreatic Cancer
Haiyang Sun et al, 2020, BioMed Research International CrossRef - M6A Regulatory Genes Play an Important Role in the Prognosis, Progression and Immune Microenvironment of Pancreatic Adenocarcinoma.
Fangshi Xu et al, 2021, Cancer Invest CrossRef - Analysis of N6-Methyladenosine Methyltransferase Reveals METTL14 and ZC3H13 as Tumor Suppressor Genes in Breast Cancer
Peng-Ju Gong et al, 2020, Front. Oncol. CrossRef - Head and Neck Squamous Cell Carcinoma: Epigenetic Landscape
Kamila Romanowska et al, 2020, Diagnostics CrossRef - Identification of Transcription Factors, Biological Pathways, and Diseases as Mediated by N6-methyladenosine Using Tensor Decomposition-Based Unsupervised Feature Extraction
Y-h. Taguchi et al, 2020, Applied Sciences CrossRef - Epigenetyka jako obiecująca dziedzina nauki w walce z nowotworami głowy i szyi
Kamila Romanowska, 2021, LOS CrossRef - Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer Cells
Wenbin Xu et al, 2021, DDDT CrossRef - Context-Dependent Roles of RNA Modifications in Stress Responses and Diseases
Emma Wilkinson et al, 2021, IJMS CrossRef - Development and Validation of an m6A RNA Methylation Regulators-Based Signature for Predicting the Prognosis of Adrenocortical Carcinoma
Chengquan Shen et al, 2021, Front. Endocrinol. CrossRef - The Impact of m6A RNA Modification in Therapy Resistance of Cancer: Implication in Chemotherapy, Radiotherapy, and Immunotherapy
Omprakash Shriwas et al, 2021, Front. Oncol. CrossRef -
N
6
‐Methyladenosine (m
6
A) readers are dysregulated in renal cell carcinoma
Felix Hagen et al, 2021, Molecular Carcinogenesis CrossRef - NUCB1 Suppresses Growth and Shows Additive Effects With Gemcitabine in Pancreatic Ductal Adenocarcinoma via the Unfolded Protein Response.
Yong-Qiang Hua et al, 2021, Front Cell Dev Biol CrossRef - Clinical and prognostic pan-cancer analysis of m6A RNA methylation regulators in four types of endocrine system tumors
Kai Li et al, 2020, Aging CrossRef - N6-methyladenosine-dependent signalling in cancer progression and insights into cancer therapies
Fenghua Tan et al, 2021, J Exp Clin Cancer Res CrossRef - Role of RNA N6-Methyladenosine Modification in Male Infertility and Genital System Tumors
Shuai Liu et al, 2021, Front. Cell Dev. Biol. CrossRef - m6A RNA Methylation Regulators Elicit Malignant Progression and Predict Clinical Outcome in Hepatocellular Carcinoma
Wenli Li et al, 2021, Disease Markers CrossRef - N6-Methyladenosine RNA Modification in Inflammation: Roles, Mechanisms, and Applications
Jiahui Luo et al, 2021, Front. Cell Dev. Biol. CrossRef - An m6A-Related Prognostic Biomarker Associated With the Hepatocellular Carcinoma Immune Microenvironment.
Yingxi Du et al, 2021, Front Pharmacol CrossRef - Expression Status and Prognostic Value of m6A RNA Methylation Regulators in Lung Adenocarcinoma
Xiuhong Li et al, 2021, Life CrossRef - ATF3 Modulates the Resistance of Breast Cancer Cells to Tamoxifen through an N6-Methyladenosine-Based Epitranscriptomic Mechanism
Xiaochuan Liu et al, 2021, Chem. Res. Toxicol. CrossRef - m6A Modification: A Double-Edged Sword in Tumor Development.
Runnan Gao et al, 2021, Front Oncol CrossRef - Role of m6A methylation in occurrence and progression of digestive system malignancies
Rui-Huang Liang et al, 2021, WCJD CrossRef - Quantification of m6A RNA methylation modulators pattern was a potential biomarker for prognosis and associated with tumor immune microenvironment of pancreatic adenocarcinoma.
Lianzi Wang et al, 2021, BMC Cancer CrossRef - m6A Methyltransferase METTL14-Mediated Upregulation of Cytidine Deaminase Promoting Gemcitabine Resistance in Pancreatic Cancer.
Congjun Zhang et al, 2021, Front Oncol CrossRef - Characterization of Modification Patterns, Biological Function, Clinical Implication, and Immune Microenvironment Association of m6A Regulators in Pancreatic Cancer
Kun Fang et al, 2021, Front. Genet. CrossRef - Effect, Mechanism, and Applications of Coding/Non-coding RNA m6A Modification in Tumor Microenvironment
Chaohua Si et al, 2021, Front. Cell Dev. Biol. CrossRef - Integration Analysis of m6A Related Genes in Skin Cutaneous Melanoma and the Biological Function Research of the SPRR1B
Shupeng Shi et al, 2021, Front. Oncol. CrossRef - Single-Cell Multiomics Analysis for Drug Discovery
Sam F. Nassar et al, 2021, Metabolites CrossRef - Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer.
Yongdong Guo et al, 2021, Front Immunol CrossRef - Aerial View of the Association Between m6A-Related LncRNAs and Clinicopathological Characteristics of Pancreatic Cancer
Bowen Huang et al, 2022, Front. Oncol. CrossRef - Comprehensive Analysis of Differentially Expressed Profiles of mRNA N6-Methyladenosine in Colorectal Cancer
Na Li et al, 2022, Front. Cell Dev. Biol. CrossRef - The N6-Methyladenosine Modification and Its Role in mRNA Metabolism and Gastrointestinal Tract Disease
Teng Cai et al, 2022, Front. Surg. CrossRef - Interplay Between m6A RNA Methylation and Regulation of Metabolism in Cancer
Youchaou Mobet et al, 2022, Front. Cell Dev. Biol. CrossRef - Epitranscriptomic Reprogramming Is Required to Prevent Stress and Damage from Acetaminophen
Sara Evke et al, 2022, Genes CrossRef - An Overview of Epigenetic Methylation in Pancreatic Cancer Progression
Yuhao Zhao et al, 2022, Front. Oncol. CrossRef - Roles of RNA Modifications in Diverse Cellular Functions
Emma Wilkinson et al, 2022, Front. Cell Dev. Biol. CrossRef - Methyltransferase-like 3 Aggravates HCC Development via Mediating N6-Methyladenosine of Ubiquitin-Specific Protease 7
Daiyue Yuan et al, 2022, Journal of Oncology CrossRef - The Potential Value of m6A RNA Methylation in the Development of Cancers Focus on Malignant Glioma
Fan Chen et al, 2022, Front. Immunol. CrossRef - Role of N6-Methyladenosine Methylation Regulators in the Drug Therapy of Digestive System Tumours
Zhelin Xia et al, 2022, Front. Pharmacol. CrossRef - Meta analysis of bioactive compounds, miRNA, siRNA and cell death regulators as sensitizers to doxorubicin induced chemoresistance
Sruthi Sritharan et al, 2022, Apoptosis CrossRef - Crosstalk among m6A RNA methylation, hypoxia and metabolic reprogramming in TME: from immunosuppressive microenvironment to clinical application.
Fusheng Zhang et al, 2022, J Hematol Oncol CrossRef - The Emerging Role of RNA N6-Methyladenosine Modification in Pancreatic Cancer
Xiaoge Hu et al, 2022, Front. Oncol. CrossRef - Multifaceted Roles of the N6-Methyladenosine RNA Methyltransferase METTL3 in Cancer and Immune Microenvironment
Chenxi Hu et al, 2022, Biomolecules CrossRef - SETD2 regulates gene transcription patterns and is associated with radiosensitivity in lung adenocarcinoma
Zihang Zeng et al, 2022, Front. Genet. CrossRef - YTHDF3 Is Involved in the Diapause Process of Bivoltine Bombyx mori Strains by Regulating the Expression of Cyp307a1 and Cyp18a1 Genes in the Ecdysone Synthesis Pathway
Yanhua Chen et al, 2022, Biomolecules CrossRef - The role of RNA modification in hepatocellular carcinoma
Qiang Feng et al, 2022, Front. Pharmacol. CrossRef - METTL16 predicts a favorable outcome and primes antitumor immunity in pancreatic ductal adenocarcinoma
Liting Lu et al, 2022, Front. Cell Dev. Biol. CrossRef - Epigenetic Regulation of Methylation in Determining the Fate of Dental Mesenchymal Stem Cells
Hui Zhang et al, 2022, Stem Cells International CrossRef - METTL3 suppresses anlotinib sensitivity by regulating m6A modification of FGFR3 in oral squamous cell carcinoma
Jie Chen et al, 2022, Cancer Cell Int CrossRef - Transcriptome-wide m6A methylome analysis uncovered the changes of m6A modification in oral pre-malignant cells compared with normal oral epithelial cells
Xun Chen et al, 2022, Front. Oncol. CrossRef - The Role of N6-Methyladenosine Modification in Microvascular Dysfunction
Ye-Ran Zhang et al, 2022, Cells CrossRef - Identification of genes modified by N6-methyladenosine in patients with colorectal cancer recurrence
Qianru Zhu et al, 2022, Front. Genet. CrossRef - The Role of m6A Modification and m6A Regulators in Esophageal Cancer
Yuekao Li et al, 2022, Cancers CrossRef -
A dynamic reversible RNA N
6
‐methyladenosine modification: current status and perspectives
Zhen Bi et al, 2019, Journal Cellular Physiology CrossRef - N6-methyladenosine RNA methylation: From regulatory mechanisms to potential clinical applications
Peipei Li et al, 2022, Front. Cell Dev. Biol. CrossRef - RNA Modifications Meet Tumors
Zhiyuan Yang et al, 2022, CMAR CrossRef - Biological and pharmacological roles of m6A modifications in cancer drug resistance
Zaoqu Liu et al, 2022, Mol Cancer CrossRef - RNA methylation and cellular response to oxidative stress-promoting anticancer agents
Marco Ponzetti et al, 2023, Cell Cycle CrossRef - METTL3 from Target Validation to the First Small-Molecule Inhibitors: A Medicinal Chemistry Journey
Francesco Fiorentino et al, 2023, J. Med. Chem. CrossRef - METTL3/14 and IL‐17 signaling contribute to CEBPA‐DT enhanced oral cancer cisplatin resistance
Xue Qiao et al, 2023, Oral Diseases CrossRef - Insights into the role of nucleotide methylation in metabolic-associated fatty liver disease
Ni Zhang et al, 2023, Front. Immunol. CrossRef - Application and Prospect between m6A and LncRNA in Pancreatic Cancer
刚霞 朱, 2023, ACM CrossRef - Exploring m6A‐RNA methylation as a potential therapeutic strategy for acute lung injury and acute respiratory distress syndrome
Reem Faraj et al, 2023, Pulm. circ. CrossRef - The role of m6A methylation in therapy resistance in cancer
Hengzhao Zhuang et al, 2023, Mol Cancer CrossRef - N6-methyladenosine RNA modifications: a potential therapeutic target for AML
Rong Hu et al, 2023, Ann Hematol CrossRef - Mechanisms of sunitinib resistance in renal cell carcinoma and associated opportunities for therapeutics
Yunxia Wang et al, 2023, British J Pharmacology CrossRef - null
Elena Arechaga-Ocampo, 2023 CrossRef - Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner
Pei Cao et al, 2024, Cancer Res Treat CrossRef - YTHDF2 promotes gastric cancer progression and enhances chemoradiotherapy resistance
Jian Yang et al, 2024, Drug Development Research CrossRef - Mechanisms and clinical landscape of N6-methyladenosine (m6A) RNA modification in gastrointestinal tract cancers
Dan-Hua Zhu et al, 2024, Mol Cell Biochem CrossRef